Evidence map›Paper›PMID 40919545›Full record

ArticlePalliative medicine reports2025

Place of Death of Cancer Patients Treated at a German Comprehensive Cancer Center.

Julia Berendt, Maria Heckel, Christoph Ostgathe, Stephanie Stiel, Peter Stachura, Andreas Becker, Matthias W Beckmann, Susanne Gahr

Abstract read
In one paragraph

Article in Palliative medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julia BerendtDepartment of Palliative Medicine, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Centres, CCC Erlangen-EMN, Comprehensive Cancer Centres Alliance WERA (CCC WERA), Bavarian Cancer Research Centres (BZKF), Erlangen, Germany.
Maria HeckelDepartment of Palliative Medicine, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Centres, CCC Erlangen-EMN, Comprehensive Cancer Centres Alliance WERA (CCC WERA), Bavarian Cancer Research Centres (BZKF), Erlangen, Germany.
Christoph OstgatheDepartment of Palliative Medicine, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Centres, CCC Erlangen-EMN, Comprehensive Cancer Centres Alliance WERA (CCC WERA), Bavarian Cancer Research Centres (BZKF), Erlangen, Germany.
Stephanie StielDepartment of Palliative Medicine, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Centres, CCC Erlangen-EMN, Comprehensive Cancer Centres Alliance WERA (CCC WERA), Bavarian Cancer Research Centres (BZKF), Erlangen, Germany.
Peter StachuraDepartment of Palliative Medicine, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Centres, CCC Erlangen-EMN, Comprehensive Cancer Centres Alliance WERA (CCC WERA), Bavarian Cancer Research Centres (BZKF), Erlangen, Germany.
Andreas BeckerMedical Informatics and Communication Centres, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Centres, CCC Erlangen-EMN, Comprehensive Cancer Centres Alliance WERA (CCC WERA), Bavarian Cancer Research Centres (BZKF), Erlangen, Germany.
Matthias W BeckmannDepartment of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Centres, CCC Erlangen-EMN, Comprehensive Cancer Centres Alliance WERA (CCC WERA), Bavarian Cancer Research Centres (BZKF), Erlangen, Germany.
Susanne GahrDepartment of Palliative Medicine, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Centres, CCC Erlangen-EMN, Comprehensive Cancer Centres Alliance WERA (CCC WERA), Bavarian Cancer Research Centres (BZKF), Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Public health research includes end-of-life care. Place of death is an indicator of end-of-life care quality. Objective: We assessed the place of death of cancer patients treated at a Comprehensive Cancer Center (CCC), caring for an average of 2220 primary cases per year. Methods: Dataset includes information on cancer patients who were treated at least once in a German CCC, died between 2009 and 2013, and for whom a place of death could be assigned. Data-reported following the "REporting of Studies Conducted Using Observational Routinely Collected Data" guideline-were retrieved from death registration and analyzed retrospectively. Descriptive analyses, frequency calculations, Pearson/Cramer's V chi-square tests, and Results: A total of 5855 patients were analyzed (metastases Conclusion: Even if treated in certified centers, CCC cancer patients have a high in-hospital mortality rate. The place of death reflects care structures and disease progression, highlighting the need for palliative care. As frequent death sites, CCCs should offer specialized palliative services. Further research is needed to better align the place of death with patient wishes.

Indexed as

cancerend-of-life carehome carehospitalpalliative careplace of death

Identifiers

PMID40919545
PMCPMC12410330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.